Clinical trial

Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension

NCT06608472

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2027-01-30

PhasePHASE3

Study timeline

Study start (estimated)2027-01-30Date precision: day

Registry last updated2026-09-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Essential Arterial Hypertensionunresolved

Interventions

N0877DRUG

Benicar HCT ® Tablets 40 mg/25 mgDRUG

Sponsors & collaborators

Eurofarma Laboratorios S.A.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06608472 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.